This live session has been archived
Wed,
Jun 24, 2020 |
7:00PM -
8:30PM EDT
Humber River Health Presents
Changing World in the Management of CHF
Rebecca Allan, MD, FRCPC
Topics: CHF
This live session has been archived
Session evaluations are closed but you may download a copy of your certificate of attendance.
Moderated by: Dr. Arthur Kushner
Details
Objectives
- Review VICTORIA trial of vericiguat, mechanism, design, possible future use.
- Review SGLT2 inhibitors and use in CHF
- Review DAPA-HF trial of dapagliflizon, mechanism, design, use, Canadian Guidelines.
- Review PARAGON trial of sacubitril/valsartan in HFPEF, design use, Canadian Guidelines
- Review latest Evidence mechanisms/phenotypes HFPEF
Faculty
Rebecca Allan MD, FRCPC
Cardiologist, Humber River Hospital